Angel Yeast Expands Into Probiotics R&D and Production, Advances Biotech Transformation
Angel Yeast Expands Into Probiotics R&D and Production, Advances Biotech Transformation
SHANGHAI, Aug. 26, 2024 /PRNewswire/ -- Angel Yeast (SH600298), a global leader in yeast manufacturing, has officially put its plateau probiotics project into production in Xizang, a milestone of the company's biotech transformation strategy and a key step to achieve local, industrialized production of probiotics.
上海,2024年8月26日/新华社——全球领先的酵母制造商安吉尔酵母(SH600298)正式将其高原益生菌项目投入生产,这是公司生物技术转型战略的里程碑,也是实现当地工业化益生菌生产的关键步骤。
The probiotics product can be applied in the food, healthcare, agriculture industries and more, boasting huge economic value and market potential. Angel Yeast's probiotics production now focuses on three main industrialized strains – the Lactobacillus plantarum S2 has strong acid-producing capacity and excellent fermentation results, which can be utilized in food and agriculture productions; the DB-8 that's mainly applied in dairy products and can make the yogurt to have a natural tomato flavor without additives, which is of high commercial value; and Streptococcus thermophilus, which can prevent the yogurt from further acidification over time to maintain the good taste.
益生菌产品可以应用于食品、保健品、农业等行业,具有巨大的经济价值和市场潜力。安吉尔酵母的益生菌生产现主要集中在三个主要工业菌株上-乳酸杆菌植物乳杆菌S2具有较强的产酸能力和良好的发酵结果,可应用于食品和农业生产中;Db-8主要应用于乳制品,可以使酸奶具有天然的番茄风味,无需添加剂,具有很高的商业价值;而嗜热链球菌可以防止酸奶随着时间的推移进一步酸化,以保持良好的口感。
He Xinzhang, general manager of Angel Yeast's subsidiary in Xizang, noted that for three years, the R&D team overcame altitude sickness and visited the herdsmen's families, collected dairy products, and traveled to the high-altitude areas to chase yaks and pick up cow dung, completing a series of microbial resources census collection and evaluation works with fruitful results.
安吉尔酵母在西藏子公司总经理何新章指出,研发团队三年来克服了高原反应症,走访了牧民家庭,收集了乳制品,并前往高海拔地区追逐牦牛和扫牛粪,完成了一系列微生物资源普查和评估工作,取得了丰硕的成果。
"We collected and preserved over 1,800 bacterial strains and identified the ones to be industrialized. Now we not only have the patent-licensed probiotic strains, but also own the independent intellectual property rights of the production process, which together build up our competitive advantages in the market," said He. "And as we expand the probiotics project in Xizang we're also building a local talent pipeline of management, finance, and equipment professionals."
何新章说:“我们收集并保存了1800多株细菌菌株,并鉴定出了可工业化的菌株。现在我们不仅拥有专利许可的益生菌菌株,而且拥有独立的生产工艺的知识产权,共同为我们在市场上建立竞争优势。”“随着我们在西藏扩大益生菌项目,我们还在建设一支本地的管理、财务和设备专业人才队伍。”
The Xizang Angel Zhufeng Biotechnology Co., Ltd. owns full independent property rights from the key strains to production processes, and the factory workshop is fully digitalized and automated to achieve automatic control, fully enclosed conveying, digital management and quality tracing of all sections.
西藏安吉尔珠峰生物科技有限公司从关键菌株到生产工艺拥有完全独立的知识产权,工厂车间全面数字化和自动化实现全自动控制、全封闭输送、数字化管理和质量追溯的所有环节。
Looking ahead, Angel Yeast will carry out its strategic roadmap of biotech transformation and accelerate development with innovation as the catalyst. The company is developing four new key biotech sectors – microorganisms and cell cultures, biocatalysis and enzymes, biomaterials, and biotechnology services, while promoting the applications of synthetic biology in the fields of healthcare, bio-agriculture, biomaterials and more.
展望未来,安琪酵母将执行其生物技术转型的战略路线图,并以创新作为催化剂加速发展。该公司正在开发四个新的关键生物技术领域-微生物和细胞培养,生物催化和酶,生物材料以及生物技术服务,同时推进合成生物学在医疗保健,生物农业,生物材料等领域的应用。
Photo -
Logo -
照片-
标志 -